JP2020011909A - 洗浄料 - Google Patents
洗浄料 Download PDFInfo
- Publication number
- JP2020011909A JP2020011909A JP2018132953A JP2018132953A JP2020011909A JP 2020011909 A JP2020011909 A JP 2020011909A JP 2018132953 A JP2018132953 A JP 2018132953A JP 2018132953 A JP2018132953 A JP 2018132953A JP 2020011909 A JP2020011909 A JP 2020011909A
- Authority
- JP
- Japan
- Prior art keywords
- protease
- detergent
- enzyme
- content
- total amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003599 detergent Substances 0.000 title abstract description 27
- 108091005804 Peptidases Proteins 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229930182478 glucoside Natural products 0.000 claims abstract description 8
- 239000004094 surface-active agent Substances 0.000 claims description 22
- 150000005846 sugar alcohols Polymers 0.000 claims description 20
- 239000012459 cleaning agent Substances 0.000 claims description 19
- 125000004442 acylamino group Chemical group 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 10
- -1 alkyl glucoside Chemical class 0.000 claims description 7
- 102000035195 Peptidases Human genes 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 4
- 229960003237 betaine Drugs 0.000 claims description 4
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims 1
- 239000004365 Protease Substances 0.000 abstract description 30
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 28
- 239000000203 mixture Substances 0.000 abstract description 28
- 239000006071 cream Substances 0.000 abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 9
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 abstract description 8
- 230000001815 facial effect Effects 0.000 abstract description 7
- 235000011187 glycerol Nutrition 0.000 abstract description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 abstract description 6
- 150000008131 glucosides Chemical class 0.000 abstract description 4
- 229940116335 lauramide Drugs 0.000 abstract description 4
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 abstract description 4
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 abstract description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 abstract description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract description 3
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 abstract description 3
- 229940100608 glycol distearate Drugs 0.000 abstract description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 abstract description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 abstract description 3
- 229960002216 methylparaben Drugs 0.000 abstract description 3
- 229960005323 phenoxyethanol Drugs 0.000 abstract description 3
- 229910052708 sodium Inorganic materials 0.000 abstract description 3
- 239000000230 xanthan gum Substances 0.000 abstract description 3
- 235000010493 xanthan gum Nutrition 0.000 abstract description 3
- 229920001285 xanthan gum Polymers 0.000 abstract description 3
- 229940082509 xanthan gum Drugs 0.000 abstract description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 33
- 108090000790 Enzymes Proteins 0.000 description 33
- 229940088598 enzyme Drugs 0.000 description 33
- 235000019419 proteases Nutrition 0.000 description 27
- 230000000052 comparative effect Effects 0.000 description 24
- 230000000694 effects Effects 0.000 description 23
- 239000006260 foam Substances 0.000 description 21
- 238000003860 storage Methods 0.000 description 17
- 239000011734 sodium Substances 0.000 description 15
- 238000000926 separation method Methods 0.000 description 14
- 230000007423 decrease Effects 0.000 description 12
- 230000000717 retained effect Effects 0.000 description 9
- 235000019645 odor Nutrition 0.000 description 8
- 239000003381 stabilizer Substances 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000001771 impaired effect Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 238000005187 foaming Methods 0.000 description 5
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- ATFFFUXLAJBBDE-FQEVSTJZSA-N N-Stearoyl glutamic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ATFFFUXLAJBBDE-FQEVSTJZSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 229940071136 stearoyl glutamate Drugs 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- MTJZWYHTZFVEGI-INIZCTEOSA-N (2s)-2-(tetradecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O MTJZWYHTZFVEGI-INIZCTEOSA-N 0.000 description 2
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical compound CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- 229940071085 lauroyl glutamate Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- VCRXMSMANOGRCM-ZDUSSCGKSA-N (2s)-2-(dodecanoylamino)butanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC(O)=O VCRXMSMANOGRCM-ZDUSSCGKSA-N 0.000 description 1
- ZNRLADRSOXNJKR-INIZCTEOSA-N (2s)-2-[methyl(tetradecanoyl)amino]propanoic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)[C@@H](C)C(O)=O ZNRLADRSOXNJKR-INIZCTEOSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011538 cleaning material Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229940070808 lauroyl aspartate Drugs 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
Description
なお、以下に示す組成は本発明の一例であり、本発明の内容がこれに限定されるものではない。また、洗浄料の剤型は、一例である洗顔クリームに限定されるものではなく、適宜、設定変更することができる。
本発明を適用した洗浄料の一例である洗顔クリームの実施例1〜6及び比較例1〜8の試料を作製し、以下の評価を行った。
まず、表1及び表2に示す組成となるように原料成分を配合して、実施例1〜6及び比較例1〜8の各試料を作製した。なお、以下、表1〜表7に示す数値は、原料の全量を基準にした重量比率(%)を示したものである。また、以下に示す表1〜表7では、各試料で評価を行った評価項目の結果を併せて表示する。
「日本薬局方一般試験法 消化力試験法 蛋白消化力試験法」に基づいて、蛋白分解酵素活性を測定して、酵素活性の残存率の評価を行った。酵素活性の残存率については、作製直後の試料と、40℃で30日間保存した後の試料の酵素活性とを測定し、酵素活性の残存率を算出して、蛋白分解酵素の安定性を評価した。酵素活性の残存率が70%以上のもの(表1乃至表7では◎)、60%以上のもの(表1乃至表7では〇)、50%以上のもの(表1乃至表7では△)、50%未満のもの(表1乃至表7では×)と判断した。
手のひらに各試料を2g程度付けた後、水を加えながら泡立てて、泡質について評価した。もっちりとした泡であり、使用中に泡のへたりが見られないもの(表1乃至表7では4)、もっちりとした泡であり、使用中に泡がややへたってしまうもの(表1乃至表7では3)、泡立て直後から、泡がへたってしまうもの(表1乃至表7では2)、泡に全くこしがないもの(表1乃至表7では1)と判断した。
腕の内側に泡立てた試料を付け、10秒マッサージした後に流水ですすぎ、すすぎ後のしっとり感について評価した。しっとり感を強く感じるもの(表1乃至表7では4)、しっとり感を感じるもの(表1乃至表7では3)、しっとり感を感じるが弱いもの(表1乃至表7では2)、全くしっとり感を感じないもの(表1乃至表7では1)と判断した。
40℃で30日間保存した後、各試料について、褐変の発生の観察及び変臭の発生の確認を行った。褐変の発生及び変臭の発生については、あり、ややあり、なしの三段階で判断をした。
50℃で30日間保存した後に、試料の安定性(粘度や分離の有無、析出の有無等)について、目視で観察を行った。外観の変化が全くなく、粘度低下や分離が観察されないもの(表1乃至表7では◎)、ごく僅かに粘度低下や分離が認められるもの(表1乃至表7では〇)、粘度低下や分離が認められるもの(表1乃至表7では△)、明らかに粘度低下や分離が認められもの(表1乃至表7では×)と判断した。
表3及び表4に示す組成となるように原料成分を配合して、実施例7〜14及び比較例9〜16の各試料を作製し、上記(2)〜(6)の評価を行った。
表5に示す組成となるように原料成分を配合して、実施例2及び比較例17〜22の各試料を作製し、上記(2)〜(6)の評価を行った。
表6及び表7に示す組成となるように原料成分を配合して、実施例2、3、15〜20及び比較例23〜29の各試料を作製し、上記(2)〜(6)の評価を行った。
Claims (3)
- 蛋白分解酵素と、
水と、
含有量が全量基準で5〜15%であるアシルアミノ酸系界面活性剤を含む界面活性剤と、
含有量が全量基準で20〜35%である多価アルコールとを含有する
洗浄料。 - 前記水及び前記多価アルコールの含有量の比率が水1に対して多価アルコールが0.30〜0.90の範囲内である
請求項1に記載の洗浄料。 - 前記界面活性剤は、アミドアルキルベタイン及び/またはアルキルグルコシドを含む
請求項1または請求項2に記載の洗浄料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018132953A JP6918361B2 (ja) | 2018-07-13 | 2018-07-13 | 洗浄料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018132953A JP6918361B2 (ja) | 2018-07-13 | 2018-07-13 | 洗浄料 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020011909A true JP2020011909A (ja) | 2020-01-23 |
JP6918361B2 JP6918361B2 (ja) | 2021-08-11 |
Family
ID=69168681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018132953A Active JP6918361B2 (ja) | 2018-07-13 | 2018-07-13 | 洗浄料 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6918361B2 (ja) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002037726A (ja) * | 2000-07-25 | 2002-02-06 | Kose Corp | 洗浄料組成物 |
JP2004307360A (ja) * | 2003-04-02 | 2004-11-04 | Kose Corp | 洗浄料組成物 |
JP2004307568A (ja) * | 2003-04-02 | 2004-11-04 | Kose Corp | 洗浄料組成物 |
JP2005192403A (ja) * | 2003-12-26 | 2005-07-21 | Lion Corp | プロテアーゼ、および該プロテアーゼを含む皮膚洗浄剤組成物 |
JP2005192407A (ja) * | 2003-12-26 | 2005-07-21 | Omori Shokken:Kk | ドレッシング及びその製造方法 |
JP2005306822A (ja) * | 2004-04-26 | 2005-11-04 | Kansai Koso Kk | 蛋白分解酵素安定化剤、化粧料及び洗浄剤 |
-
2018
- 2018-07-13 JP JP2018132953A patent/JP6918361B2/ja active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002037726A (ja) * | 2000-07-25 | 2002-02-06 | Kose Corp | 洗浄料組成物 |
JP2004307360A (ja) * | 2003-04-02 | 2004-11-04 | Kose Corp | 洗浄料組成物 |
JP2004307568A (ja) * | 2003-04-02 | 2004-11-04 | Kose Corp | 洗浄料組成物 |
JP2005192403A (ja) * | 2003-12-26 | 2005-07-21 | Lion Corp | プロテアーゼ、および該プロテアーゼを含む皮膚洗浄剤組成物 |
JP2005192407A (ja) * | 2003-12-26 | 2005-07-21 | Omori Shokken:Kk | ドレッシング及びその製造方法 |
JP2005306822A (ja) * | 2004-04-26 | 2005-11-04 | Kansai Koso Kk | 蛋白分解酵素安定化剤、化粧料及び洗浄剤 |
Also Published As
Publication number | Publication date |
---|---|
JP6918361B2 (ja) | 2021-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2964226B2 (ja) | 洗浄剤組成物 | |
WO2006030881A1 (ja) | 洗浄剤組成物 | |
KR20060009896A (ko) | 세정제 조성물 | |
AU2007340759A1 (en) | Detergent composition | |
JP2018002719A (ja) | 口腔用組成物 | |
KR101168434B1 (ko) | 세정제 조성물 | |
JP2000160196A (ja) | 固形せっけん | |
KR100346315B1 (ko) | 세정제조성물 | |
JP4830305B2 (ja) | 弱酸性泡状洗浄剤組成物 | |
JP4397269B2 (ja) | 蛋白分解酵素安定化剤、化粧料及び洗浄剤 | |
JP4406982B2 (ja) | 固形石鹸 | |
JP2020011909A (ja) | 洗浄料 | |
JP2001200294A (ja) | 固形せっけん | |
JP2007099742A (ja) | シャンプー剤組成物 | |
JP6225697B2 (ja) | 固形石けん | |
KR20170050414A (ko) | 인체 세정제 조성물 | |
KR101062626B1 (ko) | 세정제 조성물 | |
JP2006306908A (ja) | 洗浄剤組成物 | |
KR102402933B1 (ko) | 스핑고모나스발효추출물을 포함하는 모발 세정제 조성물 | |
JP3621441B2 (ja) | 皮膚用洗浄剤組成物 | |
JP6361116B2 (ja) | 皮膚洗浄剤組成物 | |
JP4320049B2 (ja) | 皮膚洗浄料 | |
JP7150050B2 (ja) | 皮膚洗浄剤組成物 | |
JP7036544B2 (ja) | 皮膚洗浄剤組成物 | |
JP2001064691A (ja) | 洗浄剤組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190719 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200601 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200616 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200728 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201012 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210224 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210407 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210629 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210714 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6918361 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |